MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration stockholder rights plan ("Rights Plan")...
Pharma Inc Anson Advisors Inc Cable Car Group Pharma Adopts Company Annual Report On Form Exchange Commission
Source: lelezard.com